Dr. LaPensee’s profile demonstrates a deep involvement in health economics, outcomes research, and market access. He currently leads these efforts at Paratek Pharmaceuticals and has done so for Skylands Healthcare Consulting since 2014. His work involves developing evidence from clinical trials and insurance claims to support product value assessments. He also publishes peer-reviewed articles on cost-effectiveness models, which adds to his credibility. While his qualifications are extensive, ranging from a PhD at the University of Connecticut to senior roles at The Medicines Company, the specific scope of his consulting services could be clearer. For potential clients, it would be helpful to know exactly how he structures his advisory engagements. Nevertheless, his track record in supporting pharma and biotech companies on pricing and reimbursement seems solid and well-documented.
Questions about Kenneth LaPensee
What is Kenneth LaPensee?
Kenneth LaPensee is a health economics and outcomes research professional who serves as the director of health economics and outcomes research at Paratek Pharmaceuticals, supporting value assessments and cost calculations for hospital-administered antibiotics used in acute bacterial skin and skin structure infections and community-acquired bacterial pneumonia. He also owns Skylands Healthcare Consulting LLC, where he advises pharmaceutical and biotechnology companies on pricing, reimbursement, and market access. His work involves developing evidence from clinical trials, healthcare registries, and economic models to support product value assessments for health systems and payers.
How long has this business existed?
Skylands Healthcare Consulting LLC has been operating since 2014, when Kenneth LaPensee began serving as its principal and owner. The firm specializes in advising pharmaceutical and biotechnology companies on studies, pricing, reimbursement, and market access barriers. This long-standing experience allows the business to provide established expertise in healthcare economic modeling and product coverage evidence.
Where is the business located and what is its digital footprint?
The business is located in Hampton, NJ, and operates under the domain aboutkennethlapensee.com. Kenneth LaPensee also maintains a presence through his personal website which outlines his background in health services, epidemiology, and quantitative methods. His professional history includes roles at Forest Research Institute and The Medicines Company, demonstrating a broad network in the healthcare sector.
What educational background supports Kenneth LaPensee's expertise?
Kenneth LaPensee earned his PhD from the University of Connecticut, where he studied anthropology, social science, and health services. He later pursued additional training in epidemiology and quantitative methods at Rutgers School of Public Health. These educational foundations support his current role in health economics and outcomes research, providing a strong academic background for his consulting work.
What specific services does Skylands Healthcare Consulting LLC offer?
Kenneth LaPensee's consulting services cover a range of topics including pricing, reimbursement, and market access barriers. His work with biotechnology companies involves creating studies and evidence to support product coverage. These services are tailored to meet the specific needs of pharmaceutical and biotechnology firms looking to optimize their market strategies.
How does Kenneth LaPensee's experience compare with other professionals in the field?
The business has a history of working with major pharmaceutical companies such as Forest Research Institute and The Medicines Company. This experience demonstrates a track record of success in the healthcare industry. Kenneth LaPensee's ability to navigate complex market access issues is a result of his extensive background in health economics and outcomes research.
What is the official website of Kenneth LaPensee?
The official website of Kenneth LaPensee is aboutkennethlapensee.com.
How is Kenneth LaPensee rated on Trustburn?
On Trustburn, Kenneth LaPensee has a rating of 4 out of 5 based on 5 reviews.
Post your question publicly — other visitors, and whoever manages this page, can answer. It will be visible on this page.
Want to hear about this company again? Follow it and we’ll email you when a new review appears.
Based on reviews, listing data and the company's website. Verify anything important with the company directly.
5 Reviews
It is impressive to see such a strong mix of academic rigor and industry experience. He has a PhD and has worked at top pharma companies, plus he runs his own consulting business. This suggests he really understands both the science and the business side of healthcare economics.
His background in health economics and outcomes research is clearly detailed. With roles at major pharmaceutical firms and his own consulting firm, he seems well-positioned to advise on market access and reimbursement strategies for healthcare products.
I looked into his consulting services through Skylands Healthcare Consulting. It seems like he covers pricing and market access for pharma companies, which is pretty niche. The website lists his roles at Paratek and The Medicines Company, so he definitely has the background. However, it is not entirely clear what specific deliverables or costs are included in his consulting engagements. If you are thinking of hiring him for reimbursement support or economic models, you should probably check the terms first. The site mentions he advises on studies and coverage evidence, but does not spell out the scope clearly for a new client. Just make sure you verify what you are getting before committing.
From the information available, Dr. Kenneth LaPensee presents as a highly qualified professional in health economics and outcomes research. His background spans pharmaceutical research, market access, and healthcare economic modeling, which suggests a robust understanding of complex healthcare systems. He currently directs health economics and outcomes research at Paratek Pharmaceuticals, focusing on value messages and cost calculations for specific antibiotics. Additionally, his long-standing role as principal owner of Skylands Healthcare Consulting LLC indicates significant experience advising pharmaceutical and biotechnology companies on pricing and reimbursement barriers. His academic credentials, including a PhD from the University of Connecticut and studies at Rutgers, further support his expertise. For anyone seeking specialized knowledge in health economic modeling and evidence-based product value assessments, his profile appears comprehensive and well-supported by both academic and industry experience.
Questions & Answers
No questions yet — be the first to ask.
Sign in to post
Your text is saved — you'll come right back to post.
Don't have an account? Create one
News & Press
No news yet. This is where the business shares its own updates and press.
Photos
No photos yet. Photos shared by reviewers will show up here.
About Kenneth LaPensee
Kenneth LaPensee is a health economics and outcomes research professional with experience in pharmaceutical research, market access, reimbursement support, and healthcare economic modeling. He works as the director of health economics and outcomes research at Paratek Pharmaceuticals, supporting value assessments and cost calculations for hospital-administered antibiotics. Since 2014, he has served as principal and owner of Skylands Healthcare Consulting LLC, advising pharmaceutical and biotechnology companies on pricing, reimbursement, market access, and product coverage evidence. His background includes a PhD from the University of Connecticut and additional training in epidemiology and quantitative methods at Rutgers School of Public Health. He has also held senior roles at Forest Research Institute and The Medicines Company, and has published peer-reviewed articles on cost effectiveness and budget impact modeling.
- Website
- aboutkennethlapensee.com
